Intimation for approval of investment in units of Vivriti Vihaan Trust, a scheme of an Alternative Investment Fund registeed under SEBI and in units of Neo Income plus Fund III, a scheme of Neo Credit Alternatives Investment Trust.
Amwill Health Care Ltd Press Release Sep 25 2026
Filed with BSE · · 1 page · English
Summary by 6ix AI
The company plans to invest in two funds to support its long-term growth strategy. This investment is approved by the Investment Committee and does not involve any related party transactions. The disclosure is made in compliance with SEBI Listing Regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Amwill Health Care
- Amwill Health Care Ltd Press Release Aug 14 2026
- Amwill Health Care Ltd Press Release Aug 08 2026
- Amwill Health Care Ltd Press Release Jul 23 2026
- Amwill Health Care Ltd Press Release Jul 21 2026
- Amwill Health Care Ltd Press Release Jul 17 2026
Later from Amwill Health Care
- Amwill Health Care Ltd Press Release Sep 28 2026
- Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Grant Of Licence/Regulatory Approval For Import Of Folicolor- Oxidative Hair Colour.
- Board Meeting Intimation for Approval And Take On Record Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026 (H1) Of Financial Year 2026-27 And Consider Declaration Of An Interim Dividend To The Equity Shareholders.
- Board Meeting Outcome for Board Meeting Outcome Of The Meeting Of The Board Of Directors Held On October 23Rd, 2026.
- Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026, For The Financial Year 2026-27.
Follow Amwill Health Care into a list and get an email when it puts out news.
Follow Amwill Health Care